NEW YORK (GenomeWeb) — OpGen today priced a public offering of 9 million shares of its common stock at $.60 per share, giving the planned transaction a $5.4 million value.
The Gaithersburg, Maryland-based company said that it has also granted the underwriters of the offering a 45-day option to buy an additional 1.35 million shares to cover overallotments. Aegis Capital acted as the sole bookrunner for the offering, which is expected to close around March 28.